FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

MTD

Mettler ToledoNYSE · Life Sciences Tools & Services · Health Care
Previous close
1,378.69
Change
+48.29 / +3.63%
FinDog View
Neutral
52-Week Range
1,023.05 – 1,525.17
P/E (TTM)
30.5
Forward P/E
29.1
Based on consensus earnings for the next 12 months
Market Cap
$27.6B
1M
−2.73%
S&P 500 −2.41% over same period
Volume / Avg Volume
356K / 185K
1.92× average

Price History

Closing price · USD1M6M1Y5Y
1000120014001600FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 32.21M6M1Y5Y
2025303540452023-082024-052025-032025-122026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 35 of its 5-year rangeMid-range
5-year range 26.0 – 40.3 · Median 32.2
Last 4 quarters: $775M in buybacks + $0 in dividends, 2.81% of market cap combined
P/E (TTM)
30.5
P/B
P/S
6.7
PEG
2.39
Earnings Reaction
Over the last 6 reports, the stock moved ±4.2% on average on the first trading day after, rising 3 times
Most recent +2.59%
Volatility & Correlation
1-year beta 0.79 · Correlation with S&P 500 0.32Tracks the market
Annualized volatility 32% vs. 13% for the S&P 500
Insider Trading
View all
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 5 · $6.1MNet selling $6.1M
  • 08-27Kaltenbach PatrickPresident and CEOSell$1.3M942 shares · Avg price 1,425.00
  • 08-05SALICE THOMAS PDirectorSell$0.60M417 shares · Avg price 1,440.41
  • 08-03Vadala ShawnChief Financial OfficerSell$3.2M2,240 shares · Avg price 1,432.00
  • 08-03Keller GerryHead of Process AnalyticsSell$0.34M240 shares · Avg price 1,427.14
  • 08-03SALICE THOMAS PDirectorSell$0.60M415 shares · Avg price 1,444.62
Multi-Quarter Financial Trends
View all quarters
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q21.03+4.5%0.230.2811.55
FY2026 Q10.95+7.2%0.170.128.33
FY2025 Q41.13+8.1%0.290.1813.91
FY2025 Q31.03+7.9%0.220.2710.57
FY2025 Q20.98+3.9%0.200.219.76
FY2025 Q10.88−4.6%0.160.187.81
FY2024 Q41.05+11.8%0.250.2211.91
FY2024 Q30.95+1.3%0.210.239.96
FY2024 Q20.95−3.6%0.220.2310.37
FY2024 Q10.93−0.3%0.180.178.24
FY2023 Q40.93−11.6%0.180.258.53
FY2023 Q30.94−4.4%0.200.249.21

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView